ATXS(Delisted)
Astria Therapeutics·NASDAQ
--
--(--)
ATXS Filings
Filing Date
Form Description
Form Type
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-09
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-02-09 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-02-02
Form 15-12G - Securities registration termination [Section 12(g)]
Key Events
2026-02-02 · Key Events
Form 15-12G - Securities registration termination [Section 12(g)]
2026-01-28
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-28 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-28
Form EFFECT - Notice of Effectiveness
2026-01-28 ·
Form EFFECT - Notice of Effectiveness
2026-01-28
Form EFFECT - Notice of Effectiveness
2026-01-28 ·
Form EFFECT - Notice of Effectiveness
2026-01-28
Form EFFECT - Notice of Effectiveness
2026-01-28 ·
Form EFFECT - Notice of Effectiveness
2026-01-28
Form EFFECT - Notice of Effectiveness
2026-01-28 ·
Form EFFECT - Notice of Effectiveness
2026-01-28
Form EFFECT - Notice of Effectiveness
2026-01-28 ·
Form EFFECT - Notice of Effectiveness
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
